Live Breaking News & Updates on Onkosxcel Therapeutics|Page 3

Stay updated with breaking news from Onkosxcel therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Q3 2023 Earnings Call Transcript

Operator: Good morning, and welcome to the BioXcel Therapeutics Conference Call, which will cover its alignment with the FDA on its TRANQUILITY program, provide an update on strategic financing, and review. ....

United States , White House , District Of Columbia , Matt Wiley , Vince Oneill , Canaccord Genuity , Vimal Mehta , Frank Yocca , Sumant Kulkarni , Greg Harrison , Rob Risinger , Ram Selvaraju , Richard Steinhart , Qatar Investment Authority , White House Office Of National Drug Control , Columbia University , Bioxcel Therapeutics Inc , Bioxcel Therapeutics , Call Transcript November , Xcel Therapeutics , Bioxcel Therapeutics Conference Call , Chief Executive Officer , Chief Financial , Chief Commercial Officer , Chief Medical Officer , Vinceo Neill ,

BioXcel Therapeutics Aligns with FDA Recommendation for Phase 3 Trial for TRANQUILITY Program, Provides Update on Strategic Financing, and Reports Third Quarter 2023 Financial Results

BioXcel Therapeutics Aligns with FDA Recommendation for Phase 3 Trial for TRANQUILITY Program, Provides Update on Strategic Financing, and Reports Third Quarter 2023 Financial Results
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

David Schull , Brennan Doyle , Vimal Mehta , Erik Kopp , Scott Stachowiak , Bioxcel Therapeutics Inc , Qatar Investment Authority , Securities Exchange , Development Rd Expenses , Aboutbioxceltherapeutics Inc , While The Company , Centers For Medicare Medicaid Services , Xcel Therapeutics Aligns , Provides Update , Strategic Financing , Reports Third Quarter , Oaktree Capital Management , Xcel Therapeutics , Two Late Stage Clinical Programs , Financing Update , Medicaid Services , Onkosxcel Therapeutics , Bioxcel Therapeutics , Breakthrough Therapy , Fast Track , Private Securities Litigation Reform Act ,

BioXcel Therapeutics (BTAI) Aligns with FDA Recommendation for Phase 3 Trial for TRANQUILITY Program, Provides Update on Strategic Financing, and Reports Third Quarter

BioXcel Therapeutics (BTAI) Aligns with FDA Recommendation for Phase 3 Trial for TRANQUILITY Program, Provides Update on Strategic Financing, and Reports Third Quarter
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Vimal Mehta , Development Rd Expenses , Qatar Investment Authority , Bioxcel Therapeutics Inc , Centers For Medicare Medicaid Services , Bioxcel Therapeutics , Two Late Stage Clinical Programs , Financing Update , Oaktree Capital Management , Medicaid Services , Onkosxcel Therapeutics , Webcastbioxcel Therapeutics , Xcel Therapeutics , Prescribing Information ,

BioXcel Therapeutics (BTAI) Reports Positive Overall Survival Results from Single-Arm, Open-Label Phase 2 Trial of BXCL701

BioXcel Therapeutics (BTAI) Reports Positive Overall Survival Results from Single-Arm, Open-Label Phase 2 Trial of BXCL701
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Vincentj Oneill , Company Phase , Prostate Cancer Foundation Annual Scientific , Bioxcel Therapeutics Inc , Bioxcel Therapeutics , Chief Rd Officer , Onkosxcel Therapeutics ,

BXCL701/Pembrolizumab Combo Prolongs OS in mCRPC of Adenocarcinoma Phenotype

Treatment with the oral innate immune activator BXCL701 combined with pembrolizumab demonstrated prolonged overall survival in patients with metastatic castration-resistant prostate cancer of adenocarcinoma phenotype. ....

Vincentj Oneill , Prostate Cancer Foundation Annual Scientific , Bioxcel Therapeutics , Onkosxcel Therapeutics , Cancer Foundation Annual Scientific , Prostate Cancer ,